Extracted text (via pymupdf)
11452 characters
Summary Federal Award Financial Information 19. Budget Period Start Date - End Date 20. Total Amount of Federal Funds Obligated by this Action 20a. Direct Cost Amount 20b. Indirect Cost Amount 21. Authorized Carryover 22. Offset 23. Total Amount of Federal Funds Obligated this budget period 24. Total Approved Cost Sharing or Matching, where applicable 25. Total Federal and Non-Federal Approved this Budget Period - End Date 26. Period of Perfomance Start Date 27. Total Amount of the Federal Award including Approved Cost Sharing or Matching this Period of Performance 28. Authorized Treatment of Program Income 29. Grants Management Officer – Signature Recipient Information Fe deral Agency Information 10.Program Official Contact Information Federal Award Information 30. Remarks 1. Recipient Name 9. Awarding Agency Contact Information Notice of Award Award# FAIN# Federal Award Date: Page 1 2. Congressional District of Recipient 3. Payment System Identifier (ID) 4. Employer Identification Number (EIN) 5. Data Universal Numbering System (DUNS) 6. Recipient’s Unique Entity Identifier (UEI) 7. Project Director or Principal Investigator 8. Authorized Official 11. Award Number 12. Unique Federal Award Identification Number (FAIN) 13. Statutory Authority 14. Federal Award Project Title 15. Assistance Listing Number 16. Assistance Listing Program Title 17. Award Action Type 18. Is the Award R&D? 09/01/2021 08/31/2023 ADDITIONAL COSTS 07 1866000472B9 Enhancing our Understanding of the Opioid Epidemic in Maricopa County in order to Augment Existing Interventions 93.136 Injury Prevention and Control Research and State and Community Based Programs Supplement No $10,214,777.00 866000472 Mr. Yarkasah Paye Pulic Health Advisor/Project Officer kvn7@cdc.gov 404.498.1839 Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES 6 NU17CE924996-03-09 6 NU17CE924996-03-09 NU17CE924996 NU17CE924996 08/10/2022 CDC Office of Financial Resources Ms. Stephanie Latham Team Lead, Grants Management Officer Mr. Max Porter Executive Director maxporter@mail.maricopa.gov 602-506-6614 MARICOPA, COUNTY OF 1645 E Roosevelt St Phoenix, AZ 85006-3638 602-506-1829 Mr. Earl Harris earl.harris@maricopa.gov 602-526-5822 $2,280,555.00 $408,405.00 08/31/2023 $4,836,857.00 $0.00 $2,247,897.00 $541,063.00 $0.00 Section 311(c)(1) of the PHS Act (42 USC § 243(c)(1)) 602062515 LM85MG1513K5 Darryl Mitchell dvm1@cdc.gov 770-488-2747 $2,588,960.00 09/01/2019 Page 2 33. Approved Budget (Excludes Direct Assistance) I. Financial Assistance from the Federal Awarding Agency Only II. Total project costs including grant funds and all other financial participation a. Salaries and Wages b. Fringe Benefits c. Total Personnel Costs d. Equipment e. Supplies f. Travel g. Construction h. Other i. Contractual j. TOTAL DIRECT COSTS INDIRECT COSTS TOTAL APPROVED BUDGET m. Federal Share n. Non-Federal Share 34. Accounting Classification Codes k. l. 31. Assistance Type 32. Type of Award Notice of Award Award# FAIN# Federal Award Date: Recipient Information Recipient Name Congressional District of Recipient Payment Account Number and Type Employer Identification Number (EIN) Data Universal Numbering System (DUNS) Recipient’s Unique Entity Identifier (UEI) $1,485,351.00 $641,487.00 $2,126,838.00 $0.00 $21,216.00 $98,130.00 $0.00 $106,851.00 $2,220,953.00 $4,573,988.00 $4,573,988.00 $2,029,147.00 $2,029,147.00 $6,603,135.00 $6,603,135.00 $5,377,920.00 $5,377,920.00 $0.00 $0.00 08/10/2022 6 NU17CE924996-03-09 NU17CE924996 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention MARICOPA, COUNTY OF 1645 E Roosevelt St Phoenix, AZ 85006-3638 602-506-1829 Cooperative Agreement 07 602062515 866000472 1866000472B9 Other LM85MG1513K5 FY-ACCOUNT NO. DOCUMENT NO. ADMINISTRATIVE CODE OBJECT CLASS CFDA NO. AMT ACTION FINANCIAL ASSISTANCE APPROPRIATION 2-9390BX6 19NU17CE924996OPCE CE 41.51 93.136 $2,588,960.00 75-22-0952 Direct Assistance BUDGET CATEGORIES PREVIOUS AMOUNT (A) AMOUNT THIS ACTION (B) TOTAL (A + B) Personnel $0.00 $0.00 $0.00 Fringe Benefits $0.00 $0.00 $0.00 Travel $0.00 $0.00 $0.00 Equipment $0.00 $0.00 $0.00 Supplies $0.00 $0.00 $0.00 Contractual $0.00 $0.00 $0.00 Construction $0.00 $0.00 $0.00 Other $0.00 $0.00 $0.00 Total $0.00 $0.00 $0.00 3 Page Notice of Award Award# FAIN# Federal Award Date: 08/10/2022 6 NU17CE924996-03-09 NU17CE924996 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention AWARD ATTACHMENTS MARICOPA, COUNTY OF 6 NU17CE924996-03-09 Terms and Conditions 1. CE19-1904 Special Terms and Conditions 2. ADDITIONAL TERMS AND CONDITIONS OF AWARD Supplemented Extension: The purpose of this amendment is to approve a 12-month extension with supplemental funds per the request submitted by your organization dated May 9, 2022. The budget and project period end dates have been extended from August 31, 2022 to August 31, 2023. Additional funds in the amount of $2,688,960 are authorized and have been distributed as indicated in the approved budget of this Notice of Award. The NOFO provides for the funding of multiple components under this award. The approved component funding levels for this notice of award are: NOFO Component Amount Surveillance $ 400,000 Prevention $ 2,288,960 Use of Unobligated Funds: This NoA includes the use of Year 2 unobligated funds in the amount of $100,000, which has been applied as an offset to the currently approved funding level for this budget period. The use of unobligated funds is approved based on the Year 2 Federal Financial Report (FFR) dated December 1, 2021. The amount of this NoA will be subject to reduction if the final amount of unobligated funds is less than the amount of unobligated funds reported on the referenced FFR. Budget Revision Requirement: Once selected, the TBD contract cost must be submitted to the CDC before costs can be expended. Failure to submit the required information in a timely manner may adversely affect the future funding of this project. If the information cannot be provided by the due date, you are required to contact the GMS/GMO identified in the CDC Staff Contacts section of this notice before the due date. Indirect Costs: Indirect Costs: Indirect costs are approved based on the recipient’s approved Cost Allocation Plan dated July 1, 2021. Final Performance Progress and Evaluation Report (PPER): This report should include the information specified in the NOFO. At a minimum, the report will include the following: • Statement of progress made toward the achievement of originally stated aims. • Description of results (positive or negative) considered significant. • List of publications resulting from the project, with plans, if any, for further publication. All manuscripts published as a result of the work supported in part or whole by the cooperative grant must be submitted with the performance progress reports. Final Federal Financial Report (FFR, SF-425): The FFR should only include those funds authorized and actually expended during the timeframe covered by the report. The Final FFR, SF-425 is required and must be submitted no later than 90 days after the period of performance end date. The final report must indicate the exact balance of unobligated funds and may not reflect any unliquidated obligations. Should the amount not match with the final expenditures reported to the Department of Health and Human Services’ PMS, you will be required to update your reports to PMS accordingly. Remaining unobligated funds will be de-obligated and returned to the U.S. Treasury. Electronic versions of the form can be downloaded at: https://www.grants.gov/web/grants/forms/post-award-reporting-forms.html#sortby=1 Equipment and Supplies - Tangible Personal Property Report (SF-428): A completed Tangible Personal Property Report SF-428 and Final Report SF-428B addendum must be submitted, along with any Supplemental Sheet SF-428S detailing all major equipment acquired or furnished under this project with a unit acquisition cost of $5,000 or more. Electronic versions of the forms can be downloaded by visiting: https://www.grants.gov/web/grants/forms/post-award-reporting-forms.html#sortby=1 If no equipment was acquired under an award, a negative report is required. The recipient must identify each item of equipment that it wishes to retain for continued use in accordance with 45 CFR Part 75. The awarding agency may exercise its rights to require the transfer of equipment purchased under the assistance award. CDC will notify the recipient if transfer to title will be required and provide disposition instruction on all major equipment. Equipment with a unit acquisition cost of less than $5,000 that is no longer to be used in projects or programs currently or previously sponsored by the Federal Government may be retained, sold, or otherwise disposed of, with no further obligation to the Federal Government. Final Invention Statement: A Final Invention Statement must be submitted. Electronic versions of the form can be downloaded by visiting http://grants1.nih.gov/grants/hhs568.pdf. If no inventions were conceived under an assistance award, a negative report is required. This statement may be included in a cover letter. CE19-1904 Overdose Data to Action Program Additional Terms and Conditions • Discontinuation of Rapid Overdose Death Detection (RODD) Activities: For the supplemental extension period, recipients that were implementing Rapid Overdose Death Detection activities will no longer be required to implement these activities. With this change, the $200,000 optional award funding for RODD will not be included in the surveillance budget for your supplemental award and CDC will no longer receive RODD data or provide technical assistance on these activities. • Recipient Self Assessments and Evaluation Plans: For the supplemental extension period, the OD2A Self-Assessment Survey is optional, to be completed on a voluntary basis. OD2A recipients are invited to complete the annual OD2A Self-Assessment survey by August 31, 2022. The survey will cover Year 3 of your work on OD2A. The survey will have each recipient’s responses from the year 2 assessment conducted last year during this same period (July - August 2021). If you choose to complete the OD2A Self-Assessment Survey, please change your responses to reflect any changes in capacity and add any additional notes. If you choose to complete the survey, CDC will provide a customized report. • Flexibility to reallocate funds Between Prevention and Surveillance Components: In response to OD2A recipient requests and to support recipient efforts to complete current year activities and activities brought forward from previous budget periods (Years 1 and 2), CDC will review requests to redirect funds between the surveillance and prevention components. The CDC Support Team will recommend approval on a case- by-case basis. Per 45 CFR 75.308- Revision of budget and program plans, prior approval is required if significant re- budgeting of current year funds is needed. Significant re-budgeting is considered a redirection of at least 25% of the total approved budget or $250,000, whichever is less.